Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Ltd (VENMAXDRUGSPHARMACEUTICALSLTD): company summary
Venmax Drugs & Pharmaceuticals Ltd (VENMAXDRUGSPHARMACEUTICALSLTD) is a micro-cap Healthcare company valued at ₹23 crore operating in Pharmaceuticals on the NSE and BSE.
Venmax Drugs & Pharmaceuticals Ltd (VENMAXDRUGSPHARMACEUTICALSLTD) is a micro-cap Healthcare company valued at ₹23 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Profit fell 4.5% a year. Return on equity is 2.7%.
- Valuation multiples
- The stock trades at 76.9 times earnings, a premium to the Healthcare median of 32.0, 1.02 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by quality (1.3). Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Revenue compounding 117% a year
- Low leverage — D/E 0.02
- Profit shrinking 5% a year
- Quality is weak (1.3/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Venmax Drugs & Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Venmax Drugs & Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Venmax Drugs & Pharmaceuticals Ltd with peers
Related tools & concepts
Value Venmax Drugs & Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

